Join the Oncology Voice Network. Join for Free
Aspiring MSL Insights: Acing Behavioral Based Job Interviews

Aspiring MSL Insights: Acing Behavioral Based Job Interviews


Share This Article


Aspiring MSL Insights: Acing Behavioral Based Job Interviews 🎯💼

👉 If you’re an aspiring MSL going into your first MSL interview, you should be preparing for #BehavioralBased #JobInterview #Questions. What are those?

👉 Michael Pietrack, the Medical Affairs recruiting lead at Kaye/Bassman International and the host of the Pharmaverse podcast, answers the question for you in this short video.

👉 A behavioral-based style interview is one that focuses on how you've handled situations in the past, rather than just discussing your skills or qualifications in theory. The idea behind this style of interviewing is that past behavior is the best predictor of future behavior. During these interviews, you'll be asked to provide specific examples from your previous work or life experiences to demonstrate how you handled certain situations, challenges, or tasks.

👉 These types of questions are easy to spot, they generally start with one of these three phrases: 👉 "Tell me about a time when..." 👉 "Give me an example of..." 👉 "Describe a situation where..."

👉 Here’s what to do: Use concrete examples rather than hypothetical answers, and keep your responses between 1-2 minutes in length. ⏱️

👉 One way to help your answer from being long and tangential is using the STAR model to structure your responses. 🌟

📗 STAR Model:

◾ (S) Situation: Describe the context or challenge, but don’t spend too much time or add more detail than necessary.

◾ (T) Task: Explain the task or goal you were working toward. This should be one sentence.

◾ (A) Action: This is the most important point. Detail the specific actions you took to address the situation.

◾ (R) Result: Share the outcomes or results of your actions. This could also be one sentence.

Follow that model when answering, and you’ll look like a pro in your MSL interview. 🏆

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Explore OVN